Stay updated on ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial
Sign up to get notified when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.

Latest updates to the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2. This is a minor system update with no changes to study data or user-facing content.SummaryDifference0.1%

- Check15 days agoChange DetectedNew Revision: v3.4.1 added. Notices about government funding lapse and the prior Revision: v3.4.0 were removed.SummaryDifference0.5%

- Check22 days agoChange DetectedA government funding lapse notice banner was added at the top of the page, informing users that information may not be up to date and that transactions may not be processed, with links to cc.nih.gov and opm.gov for status updates.SummaryDifference0.4%

- Check29 days agoChange DetectedUI updates include displaying the glossary, updating QC metadata wording (Last Update Submitted that Met QC Criteria) and No FEAR Act data capitalization, and updating the revision label to v3.4.0.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now lists Victoria as a location and shows an updated revision to v3.3.3. The HHS Vulnerability Disclosure entry and the Victoria Locations subsection have been removed.SummaryDifference0.2%

Stay in the know with updates to ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.